Interestingly, in prostate and CRC, TBX2 transcriptionally activates WNT3A which in turn activates matrix metalloproteinases (MMPs), particularly MMP2 and MMP9, as well as IL-6 to induce invasion [35,43]. Here, TBX2 is linked to colorectal carcinoma.